Literature DB >> 8236022

Comparison of outcome between extended and nonextended liver resections for neoplasms.

J N Vauthey1, H U Baer, T Guastella, L H Blumgart.   

Abstract

BACKGROUND: An aggressive approach to liver resection for neoplasms was adopted during a 5-year period. The results were evaluated by comparing the outcome between extended and nonextended liver resections.
METHODS: Among 73 consecutive patients undergoing liver resections for neoplasm or suspicion of neoplasm, 33 underwent extended liver resections (26 extended right lobectomies and 7 extended left lobectomies) and 40 underwent resections of lesser extent. Mortality, morbidity, and survival between the two groups were compared.
RESULTS: Overall morbidity was 21% and perioperative mortality was 5.4%. Morbidity and mortality were not significantly different between extended and nonextended liver resections (24% vs 18% and 6.1% vs 5.0%, respectively). Liver resections for extrahepatic cholangiocarcinomas were found to be associated with a higher morbidity (6 of 10) and mortality (2 of 10) when compared with liver resections for noncholangiocarcinomas. Bile leaks occurred mainly in patients with cholangiocarcinomas (4 of 6) and contributed to an increased overall morbidity in this series. After a median follow-up of 31 months, there was no difference in survival between extended and nonextended liver resections.
CONCLUSIONS: Extensive liver resections for neoplasms can be carried out without significant increase in the operative risk. Short-term survival is comparable between patients undergoing extended and nonextended liver resections.

Entities:  

Mesh:

Year:  1993        PMID: 8236022

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  15 in total

1.  Comparative study of perioperative management of hepatic resection.

Authors:  K Akashi; S Mizuno; S Isaji
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

Review 2.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

3.  Should hepatic resections be performed at high-volume referral centers?

Authors:  M A Choti; H M Bowman; H A Pitt; J A Sosa; J V Sitzmann; J L Cameron; T A Gordon
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.452

4.  Liver function following extended hepatectomy can be accurately predicted using remnant liver volume to body weight ratio.

Authors:  Stéphanie Truant; Emmanuel Boleslawski; Géraldine Sergent; Emmanuelle Leteurtre; Alain Duhamel; Mohamed Hebbar; François-René Pruvot
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

5.  Central hepatectomy for centrally located malignant liver tumors: A systematic review.

Authors:  Ser Yee Lee
Journal:  World J Hepatol       Date:  2014-05-27

6.  Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison.

Authors:  Ser Yee Lee; Eran Sadot; Joanne F Chou; Mithat Gönen; Thomas Peter Kingham; Peter J Allen; Ronald P DeMatteo; William R Jarnagin; Michael I D'Angelica
Journal:  HPB (Oxford)       Date:  2015-09-10       Impact factor: 3.647

7.  Is extended hepatectomy for hepatobiliary malignancy justified?

Authors:  Jean-Nicolas Vauthey; Timothy M Pawlik; Eddie K Abdalla; James F Arens; Rabih A Nemr; Steven H Wei; Debra L Kennamer; Lee M Ellis; Steven A Curley
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

Review 8.  Management of perihilar cholangiocarcinoma in the era of multimodal therapy.

Authors:  Vicente Valero; David Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2012-08       Impact factor: 3.869

9.  Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study.

Authors:  Alessandro Ferrero; Luca Viganò; Roberto Polastri; Andrea Muratore; Haris Eminefendic; Daniele Regge; Lorenzo Capussotti
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

10.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.